International Forum of Extracellular Vesicles Technology and Novel Therapeutics program
2024.11.02 SAT.
B2F, Conference Hall, Administration Building, Shuinan Campus, China Medical University
Time | Theme | Title | Speaker | Moderator |
08:00~08:30 | Registration | |||
08:30~08:40 | Opening Ceremony | Chang-Hai Tsai | ||
08:40~09:30 | Keynote Speech | Exosomes and tubular connections in membrane repair and intercellular traffic of proteins and RNA | Randy Wayne Schekman | Mien-Chie Hung |
09:30~09:40 | Group Photo | |||
09:40~10:10 | Frontier Insights | Effects of extracellular vesicles on immune checkpoint and vector development for EVs to target tumor cells | Mien-Chie Hung | Der-Yang Cho |
10:10~10:30 | Break | |||
10:30~11:00 | Pioneered Trends | Transitioning EV isolation from the bench to the bedside | Andreas Möller | Pin-Kuang Charles Lai |
11:00~11:30 | Extracellular Vesicles as a vehicle to deliver CRISPR machinery for gene therapy | Houjian Cai | ||
11:30~12:00 | HLA-G targeted exosome and its application | Jennifer Ho | ||
12:00~13:20 | Lunch | |||
13:20~13:45 | Advanced Development | Untangling the Networks of Big and Small Extracellular Vesicle In Vivo | Pin-Kuang Charles Lai |
Tzou-Yien Lin / Long-Bin Jeng |
13:45~14:10 | Engineering Extracellular Vesicles for Therapeutic Delivery | Le Thi Nguyet Minh | ||
14:10~14:35 | CD3ɛ Nanobody-Engineered Extracellular Vesicles Driving in vivo Generation of Dual-Targeting CAR-Ts for Solid Tumor Treatment | Shi-Wei Huang | ||
14:35~15:00 | Role of STAT3-FOXO3 signaling in the modulation of neuroplasticity by PD-L1-HGF-decorated mesenchymal stem cell-derived exosomes in a murine stroke model | Woei-Cheang Shyu | ||
15:00~15:25 | Rab37 mediates exosomal osteopontin secretion to promote pancreatic cancer metastasis and stemness | Yan-Shen Shan | ||
15:25~15:40 | Break | |||
15:40~16:05 | Ecosystem | Telomerized MSCs as standardized cell factories for EV production and engineering | Johannes Grillari | Chih-Hung Chang |
16:05~16:30 | Engineered extracellular vesicles for disease treatments | Chi-Ying F. Huang | ||
16:30~16:50 | Development of a Targeted Delivery Platform and Manufacturing Process for Drug-Encapsulated Extracellular Vesicles | YiWen Chen | ||
16:50~17:00 | Closing | |||
17:00 | Meeting Adjourn |
G
M
T
Y
文本转语音功能仅限200个字符